The future of implantable defibrillator and cardiac resynchronization therapy trials

Journal of Interventional Cardiac Electrophysiology

Volumn 23, Issue 1, 2008, Pages 29-39

  Saksena, Sanjeev ^a   Nagarakanti, Rangadham ^a  

^a Electrophysiology Research Foundation   (United States)

Author keywords

Cardiac resynchronization therapy; Clinical trials; Congenital heart disease; Genetics of arrhythmias; Heart failure; Implantable defibrillators; Myocardial infarction; Reviews; Sudden death; Therapy for arrhythmias; Therapy for heart failure

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAGNESIUM; METOPROLOL; MEXILETINE; OMEGA 3 FATTY ACID; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL;

CARDIAC RESYNCHRONIZATION THERAPY; CATHETER ABLATION; CLINICAL TRIAL; DEFIBRILLATOR; EARLY INTERVENTION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; HEART DEATH; HEART FAILURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SUDDEN DEATH; TREATMENT INDICATION;

ARRHYTHMIAS, CARDIAC; CLINICAL TRIALS AS TOPIC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ENDPOINT DETERMINATION; FORECASTING; HEART FAILURE; HUMANS; PATIENT SELECTION; TACHYCARDIA, VENTRICULAR;

EID: 53849130969     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-008-9302-6     Document Type: Review

References (61)

1. D. S. Lee L. D. Green P. P. Liu P. Dorian D. M. Newman F. C. Grant 2003 Effectiveness of implantable defibrillators for preventing arrhythmic events and death: A meta-analysis Journal of the American College of Cardiology 41 1573 1582
2. M. Mirowski P. R. Reid M. M. Mower L. Watkins V. L. Gott J. F. Schauble 1980 Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings The New England Journal of Medicine 303 6 322 324
3. S. Saksena N. G. Tullo R. B. Krol A. M. Mauro 1989 Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple electrode system Archives of Internal Medicine 149 2333 2339
4. S. Saksena PCD Investigator Group 1994 Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: An international multicenter study Journal of the American College of Cardiology 23 1521 1530
5. S. Saksena P. De Groot R. B. Krol R. Raju P. Matthew R. Mehra 1993 Low-energy endocardial defibrillation using an axillary or a pectoral thoracic electrode location Circulation 88 6 2655 2660
6. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators 1997 A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias The New England Journal of Medicine 337 1576 1583
7. K. H. Kuck R. Cappato J. Siebels R. Rüppel 2000 Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH) Circulation 102 748 754
8. S. J. Connolly M. Gent R. S. Roberts P. Dorian D. Roy R. S. Sheldon 2000 Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone Circulation 101 1297 1302
9. A. J. Moss W. J. Hall D. S. Cannom J. P. Daubert S. L. Higgins H. Klein 1996 Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators The New England Journal of Medicine 335 1933 1940
10. A. E. Buxton K. L. Lee J. D. Fisher M. E. Josephson E. N. Prystowsky G. Hafley 1999 A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators The New England Journal of Medicine 341 1882 1890
11. A. J. Moss W. Zareba W. J. Hall H. Klein D. J. Wilber D. S. Cannom 2002 Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction The New England Journal of Medicine 346 877 883
12. G. H. Bardy K. L. Lee D. B. Mark J. E. Poole D. L. Packer R. Boineau 2005 Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure The New England Journal of Medicine 352 225 237
13. S. L. Higgins J. D. Hummel I. K. Niazi M. C. Giudici L. A. Worley J. P. Saxon 2003 Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias Journal of the American College of Cardiology 42 1454 1459
14. J. B. Young W. T. Abraham A. L. Smith A. R. Leon R. Lieberman B. Wilkoff 2003 Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators: Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure Journal of the American Medical Association 289 2685 2694
15. M. R. Bristow L. A. Saxon J. Boehmer S. Krueger D. A. Kass T. DeMarco Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators 2004 Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure The New England Journal of Medicine 350 2140 2150
16. W. T. Abraham J. B. Young A. R. Leon S. Adler A. J. Bank S. A. Hall for the Multicenter InSync ICD II Study Group 2004 Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter- defibrillator, and mildly symptomatic chronic heart failure Circulation 110 2864 2868
17. M. H. Schoenfeld S. J. Compton R. H. Mead D. N. Weiss L. Sherfesee J. Englund 2004 Remote monitoring of implantable cardioverter defibrillators: A prospective analysis Pacing and Clinical Electrophysiology 27 757 763
18. G. K. Joseph B. L. Wilkoff T. Dresing J. Burkhardt Y. Khaykin 2004 Remote interrogation and monitoring of implantable cardioverter defibrillators Journal of Interventional Cardiac Electrophysiology 11 161 166
19. A. Lazarus 2007 Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: Analysis of a worldwide database Pacing and Clinical Electrophysiology 30 S2 S12
20. R. A. Clark S. C. Inglis F. A. McAlister J. G. Cleland S. Stewart 2007 Telemonitoring or structured telephone support programmes for patients with chronic heart failure: Systematic review and meta-analysis BMJ (Clinical Research Ed.) 334 7600 910 911
21. The DAVID Trial Investigators 2002 Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator Journal of the American Medical Association 288 24 3115 3123
22. S. Saksena 2000 Implantable defibrillators in the third millennium: Increasingly relegated to a standby role? Journal of the American College of Cardiology 36 828 831
23. P. Ott F. I. Marcus 2006 Electrocardiographic markers of sudden death Cardiology Clinics 24 3 453 469
24. V. K. Gottipaty S. P. Krelis E. P. Spencer B. G. White V. Shusterman R. Weiss for the VEST investigators 1999 QRS dispersion, unlike QT dispersion, is a predictor of all cause mortality in patients with symptomatic congestive heart failure Pacing and Clinical Electrophysiology 22 765
25. V. K. Gottipaty S. P. Krelis F. Lu E. P. Spencer V. Shusterman R. Weiss for the VEST investigators 1999 The resting electrocardiogram provides a sensitive and inexpensive marker of prognosis in patients with chronic congestive heart failure Journal of the American College of Cardiology 33 145
26. S. Goldstein B. Fagerberg A. Hjalmarson J. Kjekshus F. Waagstein H. Wedel MERIT-HF Study Group 2001 Metoprolol controlled release/extended release in patients with severe heart failure. Analysis of the experience in the MERIT-HF study Journal of the American College of Cardiology 38 932 938
27. J. A. Gomes M. E. Cain A. E. Buxton M. E. Josephson K. L. Lee G. E. Hafley 2001 Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction Circulation 104 436 441
28. M. R. Gold D. M. Bloomfield K. P. Anderson N. E. El-Sherif D. J. Wilber W. J. Groh 2000 A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification Journal of the American College of Cardiology 36 2247 2253
29. M. T. Kearney K. A. A. Fox A. J. Lee W. P. Brooksby A. M. Shah A. Flapan 2004 Predicting sudden death in patients with mild to moderate chronic heart failure Heart (British Cardiac Society) 90 1137 1143
30. M. T. La Rovere G. D. Pinna S. H. Hohnloser F. I. Marcus A. Mortara R. Nohara ATRAMI Investigators 2001 Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: Implications for clinical trials Circulation 103 2072 2077
31. M. Malik A. J. Camm M. J. Janse D. G. Julian G. A. Frangin P. J. Schwartz 2000 Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: A substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial) Journal of the American College of Cardiology 35 1263 1275
32. A. Bauer J. W. Kontelhardt P. Barthel R. Schneider T. Makikallio K. Ulm 2006 Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: Cohort study Lancet 367 1674 1681
33. Y. Iesaka A. Nogami K. Aonuma J. Nitta Y. H. Chun H. Fujiwara 1990 Prognostic significance of sustained monomorphic ventricular tachycardia induced by programmed ventricular stimulation using up to triple extrastimuli in survivors of acute myocardial infarction The American Journal of Cardiology 65 1057 1063
34. O. Costantini D. S. Rosenbaum S. H. Hohnloser M. Kirk B. Lerman J. Baker II ABCD Investigators 2006 The Alternans Before Cardioverter Defibrillator (ABCD) trial: A noninvasive strategy for primary prevention of sudden cardiac death using T-wave alternans Circulation 114 2426
35. T. Chow D. J. Kereiakes J. Onufer A. Woelfel S. Gursoy B. J. Peterson 2007 Primary results from the Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients (MASTER I) trial Circulation 116 2627 2633
36. P. Bloch-Thomsen 2008 Long-term cardiac arrhythmias recorded by an insertable loop recorder in patients with reduced ejection fraction after acute myocardial infarction: The CARISMA Study Journal of the American College of Cardiology 51 417 466
37. G. Steinbeck D. Andresen J. Senges E. Hoffmann K. Seidl J. Brachmann for the IRIS investigators as Joint Study of the German University Hospitals and German Society of Leading Cardiological Hospital Physicians (ALKK) 2004 Immediate Risk-Stratification Improves Survival (IRIS): Study protocol Europace 6 392 399
38. J. Ottervanger R. Misier F. Zijlstra M. Schalij E. Wever J. Jordaens 2006 Implantable defibrillator early after primary percutaneous intervention for ST-elevation myocardial infarction: Rationale and design of the Defibrillator After Primary Angioplasty (DAPA) Trial American Heart Journal 152 4 636 640
39. X. Jouven M. Desnos C. Guerot P. Ducimetière 1999 Predicting sudden death in the population. The Paris Prospective Study I Circulation 99 1978 1983
40. F. Sacher V. Probst Y. Iesaka P. Jacon J. Laborderie F. Mizon-Gerard 2006 Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: A multicenter study Circulation 114 2317 2324
41. Sibling Concordance for Implantable Cardioverter-Defibrillator Therapies in Ischemic Cardiomyopathy (SIBFIB) study. ClinicalTrials.gov Identifier:NCT00498524.
42. Ventricular Tachyarrhythmia (VT) Storm: Gene Expression in Implantable Cardioverter Defibrillator (ICD) Patients With Electrical Storm study. ClinicalTrials.gov identifier:NCT00284453.
43. F. Sesti G. W. Abbott J. Wei K. T. Murray S. Saksena P. J. Schwartz 2000 A common polymorphism associated with antibiotic-induced cardiac arrhythmia Proceedings of the National Academy of Sciences of the United States of America 97 10613 10618
44. DISCOVERY: Diagnostic Data and Genetic Polymorphisms in ICD Patients trial. ClinicalTrials.gov identifier: NCT00478933.
45. A. Pacifico S. H. Hohnloser J. H. Williams B. Tao S. Saksena P. D. Henry for the d, l-Sotalol Implantable Cardioverter-Defibrillator Study Group 1999 Prevention of implantable-defibrillator shocks by pretreatment with sotalol The New England Journal of Medicine 340 1855 1862
46. I. Singer H. Al-Khalidi I. Niazi P. Tchou T. Simmons R. Henthorn 2004 Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators Journal of the American College of Cardiology 43 39 43
47. F. E. Marchlinski E. S. Zado D. J. Callans V. V. Patel M. S. Ashar H. H. Hsia 2000 Hybrid therapy for ventricular arrhythmia management Cardiology Clinics 18 391 406
48. V. Y. Reddy M. R. Reynolds P. Neuzil A. W. Richardson M. Taborsky K. Jongnarangsin 2007 Prophylactic catheter ablation for the prevention of defibrillator therapy The New England Journal of Medicine 357 2657 2665
49. SMS: Substrate Modification Study in Patients Getting an Implantable Cardioverter Defibrillator (ICD). ClinicalTrials.gov identifier: NCT00170287.
50. S. Saksena 2006 Achieving global access to heart rhythm therapies in the next decade: A tangible goal Journal of Interventional Cardiac Electrophysiology 17 163 168
51. Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death (SMART-ICD) Study. ClinicalTrials.gov Identifier: NCT00524862.
52. The Extracellular Matrix Marker of Arrhythmia Risk (EMMA) trial EMMA trial. ClinicalTrials.gov Identifier: NCT00376532.
53. CHARITY: Chagas cardiomyopathy bisoprolol intervention study: A randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy. ClinicalTrials.gov Identifier: NCT00323973.
54. The Evaluation of Arrhythmic Risk in Myotonic Dystrophy (RAMYD) Trial. ClinicalTrials.gov Identifier: NCT00127582.
55. J. G. F. Cleland J.-C. Daubert E. Erdmann N. Freemantle D. Gras L. Kappenberger the Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators 2005 The effect of cardiac resynchronization on morbidity and mortality in heart failure The New England Journal of Medicine 352 1539 1549
56. G. Lin R. F. Rea S. C. Hammill D. L. Hayes P. A. Brady 2008 Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices Heart (British Cardiac Society) 94 186 190
57. A. J. Moss M. W. Brown D. S. Cannom J. P. Daubert M. Estes E. Foster 2005 Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): Design and clinical protocol Annals of Noninvasive Electrocardiology 10 4, Suppl 34 43
58. The Reducing Decompensation Events Utilizing IntraCardiac Pressures in Patients with Chronic HF (REDUCE HF) trial. ClinicalTrials.gov Identifier: NCT00354159.
59. Saksena, S., Rahme, M., Viggrano, M., Dala, P., Matthew, P. (2008). Intraoperative optimization of cardiac resynchronization therapy using intracardiac echocardiography can enhance response and outcomes in refractory heart failure. Journal of the American College of Cardiology (in press).
60. P. Sogaard H. Egeblad A. K. Pedersen W. Y. Kim B. O. Kristensen P. S. Hansen 2002 Sequential versus simultaneous biventricular resynchronization for severe heart failure: Evaluation by tissue Doppler imaging Circulation 106 16 2078 2084
61. Myogenesis Heart Efficiency and Regeneration Trial (MYOHEART) study. ClinicalTrials.gov Identifier: NCT00054678.